Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @PRISYMID
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @PRISYMID
-
Recognising our expansion from medtech and pharma into clinical trials, we have been awarded Best Performing Company for Healthcare/Government Software by
@realMegabuyte. Thanks to sponsors@GrantThorntonUK and@NatWestBusiness#software#labelling#medtech#pharma#clintrialspic.twitter.com/gd8VVZKuCk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
PRISYM ID is revolutionizing the creation of compliant artwork within Life Sciences. Read more at https://prisymid.com/software/artworkmanagement/ …pic.twitter.com/vgmiDpqWWs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Season's Greetings from the team at PRISYM ID. We would like to wish you a very Merry Christmas and a Happy New Year. We hope that you have a relaxing time, whether you're home or away!pic.twitter.com/L6JcrokEFA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PRISYM ID’s compliant labelling solution, PRISYM 360, has been selected by CME Ltd to ensure delivery of just in time clinical trials for the Medicines Manufacturing Innovation Centre - MMIC. https://tinyurl.com/r9kfzaj pic.twitter.com/iKXWhdAdM4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Do your labelling processes ensure regulatory compliance? PRISYM 360 can! Read more - https://bit.ly/2LePEKX pic.twitter.com/QbJA69DBGl
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Missed yesterday's presentation on Regional Control over Global Labeling? Fear not, we’re at the American Medical Device Summit for one more day. Stop by our booth #24 to discuss your challenges around
#EUMDR preparation.#MedTechUS19#MedicalDevicepic.twitter.com/60LCJZ6ZCx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Visiting
#MedTechUS19? Stop by our stand and learn how PRISYM ID's#Labeling and#ArtworkManagement platform can help improve FDA/EU compliance, minimise the risk of recalls and provide a watertight audit trail.#MedicalDevice#MedTech#Health#Techpic.twitter.com/lfAXPg4U9q
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Are you coming to the
@MedicalDeviceUS American#MedicalDevice Summit? Attend Richard Castle's session and learn more about the power of a global platform and how a Regulatory Rules engine aids#compliance for#EUMDR or future#regulations. https://amdsummit.com/ pic.twitter.com/DdbQyN8XJ9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Here is a 2 min video that can help you understand the new
#GS1standards for#clinicaltrials in more depth. https://prisymid.com/blog/gs1-standards-in-clinical-trial-labelling/ …pic.twitter.com/swagifTTK9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PRISYM ID proslijedio/la je Tweet
There are five key learnings that have emerged from
@PRISYMID's#UDI experience that may help inform best practice adoption with#EUMDR. See details at: https://bit.ly/2MzmsBl pic.twitter.com/iF3cDnoKo6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
NEW! Check our latest infographic.
#Annex VI is imminent. Our infographic explains how to handle the practical requirements of this regulation. https://tinyurl.com/y2cxwstz pic.twitter.com/FYP4ErY4wD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As a
#medicaldevice#EUMDR thought leader at this year#MedTechUS19@MedicalDeviceUS we are pleased to offer to our customers and prospects 60% off the event admission fee. Hope to see you there! https://lnkd.in/e56-c3p pic.twitter.com/ayqO4MYP5g
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PRISYM ID proslijedio/la je Tweet
#Software companies reported on in today’s Newswire@AptitudeSW@imimobile@Quartix@Sopheon@Netcall@ManhAssocNews@ImperoSoftware@PRISYMID Our Newswire is a subscriber service, but you can see free-to-air#mbnews here http://bit.ly/2CXUF5Z#MandA#PrivateEquity#VCHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PRISYM ID proslijedio/la je Tweet
This infographic by
@PRISYMID displays the differences between a#medicaldevice label before and after#EUMDR. Download now: https://bit.ly/2v1Au3X#meddevice#labelingpic.twitter.com/UkGlAyMwpJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PRISYM ID proslijedio/la je Tweet
This infographic by
@PRISYMID displays the differences between a#medicaldevice label before and after#EUMDR. Download now: https://bit.ly/2v1Au3X#meddevice#labelingpic.twitter.com/GjBGSH6vra
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PRISYM ID proslijedio/la je Tweet
Check out our amazing Exhibitor
@PRISYMID! Find out who else’s sponsoring#PHPLEurope http://ow.ly/CBbS50v5ErC pic.twitter.com/r2rDh7eoFy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Were you aware that
#eumdr requires that critical information be translated into 5 different languages on your labelling/packaging?#eumdr#compliance#regulationpic.twitter.com/rTEDSZLi2zHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Here’s a 2 min video from last year
#AMDS@GenerisGP@MedicalDeviceUS about#UDI lessons to help you with#EUMDR#compliance#labeling#medicaldevice












pic.twitter.com/Fdhh7teoBKHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How does
#EUMDR#UDI differ from#FDA#UDI? Here is 1 of 4 slides from Mark Cusworth's presentation tomorrow@MTI_Editor conference. http://a4343.actonsoftware.com/acton/fs/blocks/showLandingPage/a/4343/p/p-0013/t/page/fm/0 …








pic.twitter.com/9tnDaWA5aR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.